An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease

NCT04113083 · clinicaltrials.gov ↗
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class

Stopped Due To Covid-19 there were delays in the arrival of patients to the sites. Due to the rare disease in the study population, no patients who met the inclusion/exclusion criteria were found, and the study was terminated early due to these reasons.

Conditions

Interventions

Sponsor

TRPHARM

Collaborators